Market Commentary - Stock Alert
Lupin, LTIMindtree, Union Bank of India, Karnataka Bank in focus As on : 24-Nov-23  08:40

Lupin: Pharma major Lupin announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Canagliflozin Tablets, 100 mg and 300 mg, to market a generic equivalent of Invokana Tablets, 100 mg and 300 mg, of Janssen Pharmaceuticals, Inc. This product will be manufactured at Lupin?s Pithampur facility in India.

LTIMindtree: The company has launched a state-of-the-art Quantum-Safe Virtual Private Network (VPN) link at its London premises. LTIMindtree leverages its integration and domain expertise to implement and operate the Quantum-Safe VPN link across its active network.

Union Bank of India: ICRA Limited has upgraded the ratings as AAA; upgraded from AA+ and revised Outlook to ?Stable? from ?Positive? of the Instruments of the bank.

Prestige Estates Projects: The company announced the launch of Prestige Glenbrook?a highrise residential project situated in the heart of Whitefield, Bangalore's IT Hub. The development comprises of 285 apartments across two high-rise towers with a developable area of 0.7 Million sft and has a revenue potential of Rs. 550 crore.

Vishnu Chemicals: The company has incorporated Vishnu International Trading FZE, a wholly owned subsidiary in Dubai, UAE. The main objective of the new subsidiary is to distribute, transmit and sell chemicals.

Karnataka Bank: The bank has announced a strategic corporate tie-up with Bajaj Allianz Life Insurance Co Ltd, one of India's leading private life insurers to distribute life insurance products to its customers. This collaboration is designed to leverage the strength of BALIC' s product capabilities and Karnataka Bank's large customer base with wide distribution of over 900+ Branches across India.

Powered by Capital Market - Live News